NCT07598396 A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis Status RECRUITING Phase PHASE2
NCT07570862 A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis Status NOT_YET_RECRUITING Phase PHASE2
NCT07558850 Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases Status RECRUITING Phase NA
NCT07526350 MTS109 in Patients With Refractory Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT07523282 Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1
NCT07517536 CHT105 for the Treatment of Refractory Lupus Nephritis Status NOT_YET_RECRUITING Phase NA
NCT07515014 A Study of E6742 in Participants With Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2
NCT07509892 A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase PHASE2
NCT07493655 Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis Status NOT_YET_RECRUITING Phase NA
NCT07430306 A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus Status RECRUITING Phase PHASE3
NCT07410377 UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07409181 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) Status RECRUITING Phase PHASE2
NCT07408908 Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. Status NOT_YET_RECRUITING Phase PHASE1
NCT07405970 A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus Status RECRUITING Phase PHASE3
NCT07397728 " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus Status RECRUITING Phase N/A
NCT07371468 A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD) Status RECRUITING Phase PHASE1
NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) Status RECRUITING Phase PHASE1